Star Imaging and Path Lab Limited (BOM:544482)
India · Delayed Price · Currency is INR 74.70
-2.30 (-2.99%)
At close: Oct 23, 2026
Star Imaging and Path Lab Revenue
In the fiscal year ending March 31, 2026, Star Imaging and Path Lab had annual revenue of 885.27M INR with 6.02% growth. Star Imaging and Path Lab had revenue of 433.36M in the half year ending March 31, 2026. That makes Star Imaging and Path Lab the 37,648th largest company in the world by revenue and 3,310th in India.
Revenue
885.27M
Revenue Growth
+6.02%
P/S Ratio
1.52
Revenue / Employee
3.75M
Employees
236
Market Cap
1.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 885.27M | 50.27M | 6.02% |
| Mar 31, 2025 | 835.00M | 47.16M | 5.99% |
| Mar 31, 2024 | 787.84M | 202.52M | 34.60% |
| Mar 31, 2023 | 585.32M | -105.53M | -15.28% |
| Mar 31, 2022 | 690.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Modern Diagnostic & Research Centre | 839.76M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
| Clinitech Laboratory | 94.91M |